Tang ST, et al. – This study was coordinated to evaluate the stability of cancer patients’ life–sustaining treatment (LST) preferences at end of life (EOL) by identifying distinct LST–preference states and examining the probability of each state transitioning to other states between consecutive time points. The authors concluded that even when death approached, their patients’ LST preferences remained stable without prominent shifts toward preferring less aggressive LSTs. Clarifying patients' understanding and expectations regarding LST efficacy and tailoring interventions to the unique needs of patients in each state could provide personalized EOL care.